Latest News and Press Releases
Want to stay updated on the latest news?
-
Cambridge Atomworks is delighted to announce the appointment of Mr Alistair Pettey as a non-executive director.
-
Structurally-guided discovery using high-resolution cryo-EM has delivered potent, DCAF16-dependent Targeted Glues™ of SMARCA2, with exquisite selectivity over close homolog, SMARCA4.Rapid, deep and...
-
Dr. Hung-Yin Tsai, Präsident von NIAR Taiwan. (Foto: The Icons) TAIPEI, Taiwan, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Wie《The Icons》berichtet, haben das National Institutes of Applied Research (NIAR)...
-
Dr. Hung-Yin Tsai, président du NIAR de Taïwan. (Photographie : The Icons) Taipei, Taïwan, 04 août 2025 (GLOBE NEWSWIRE) -- Selon un rapport publié par « The Icons », le National...
-
Dr. Hung-Yin Tsai, President of Taiwan NIAR. (Photography: The Icons) TAIPEI, Taiwan, Aug. 04, 2025 (GLOBE NEWSWIRE) -- According to a report published by《The Icons》, Taiwan’s National Institutes...
-
Amphista Therapeutics to present novel mechanism of action for the degradation of BRD9 using its proprietary Targeted Glue® technology at two key upcoming scientific conferences Oral presentations...
-
NurExone Biologic Enhances Visibility in Pharmaceutical Industry with Technological Presentations at Major Global Events
-
Crescendo Biologics to present at the 2024 AACR Annual Meeting Cambridge, UK, 6 March 2024 – Crescendo Biologics Ltd (Crescendo), a clinical stage, immuno-oncology company developing novel, targeted...
-
PRESS RELEASE Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted protein degraders First...
-
PRESS RELEASE Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted protein degraders First...